Clinical Trial Update: Pembrolizumab In Central Nervous System Metastases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for pembrolizumab in patients with brain metastases (central nervous system involvement).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Brain Metastases | Phase 2 | Status: ACTIVE_NOT_RECRUITING